Categories: Health

NTG Nordic Transport Group A/S – H1 2025 Conference Call

 | Source: NTG Nordic Transport Group A/S

NTG Nordic Transport Group A/S – H1 2025 Conference Call

We expect to release the H1 2025 interim results of NTG Nordic Transport Group on the evening of August 11, 2025. A webcast and conference call will be held in the morning of August 12, 2025, at 10:00 am CET.

At the call, Group CEO Mathias Jensen-Vinstrup and Group CFO Christian D. Jakobsen will present the H1 2025 Interim Financial Report. The presentation will be followed by a Q&A session.

Date: August 12, 2025
Time: 10:00 am CET

To attend the conference call, please go to: Conference Call – NTG H1 2025 Interim Financial Report or Investors | NTG Nordic Transport Group.

If you wish to ask questions during the conference call, please register through this link: Conference Call Q&A – NTG H1 2025 Interim Financial Report.

We recommend participants to dial in 10 minutes prior to the scheduled start time.

Contacts

Investor Relations
Sebastian Rosborg, tel. +45 42 12 80 99, sebastian.rosborg@ntg.com

Best regards,
NTG Nordic Transport Group A/S

GlobeNews Wire

Recent Posts

NeuroDyne Drops: Sharp Mind, Enhanced Memory, and Lasting Focus As Nature Intended, Ingredients

NEURODYNE DROPS INTRODUCED AS A COGNITIVE WELLNESS SUPPLEMENT SUPPORTING HEALTHY MEMORY, FOCUS, AND MENTAL CLARITY…

53 minutes ago

Optivell Officially Announced as a Vision Support Formula for Preventive Eye Wellness

New York City, NY, Jan. 17, 2026 (GLOBE NEWSWIRE) -- OPTIVELL INTRODUCED AS A NEW…

53 minutes ago

Sugar Clean Drops: Top Blood Sugar Support Supplement for Metabolic Wellness and Energy Support

SUGAR CLEAN DROPS ANNOUNCED AS A NEW SUPPLEMENT SUPPORTING HEALTHY BLOOD SUGAR AND METABOLIC WELLNESS…

53 minutes ago

DBV Technologies Announces 166.7 Million in Gross Proceeds Following the Full Exercise of the ABSA Warrants and BS Warrants Issued on its March 2025 Financing

Châtillon, France, January 16, 2026 DBV Technologies Announces €166.7 Million in Gross Proceeds Following the…

12 hours ago

Zenas BioPharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

January 16, 2026 16:15 ET  | Source: Zenas BioPharma WALTHAM, Mass., Jan. 16, 2026 (GLOBE…

12 hours ago